Amneal director sells 50,000 shares, donates 10,000
Amneal Pharmaceuticals director John Kiely reported two transactions in Class A Common Stock on 2026-08-13.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Amneal Pharmaceuticals director John Kiely reported two transactions in Class A Common Stock on 2026-08-13. He sold 50,000 shares at a weighted average price of $17.64 per share in multiple trades within a $17.26–$17.88 range, and separately donated 10,000 shares as a charitable gift to a donor advised fund.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 50,000 shares
Net Sell
2 txns
Insider
Kiely John
Role
Director
Sold
50,000 shs ($882K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock F1 | 50,000 | $17.64 | $882K |
| Gift | Class A Common Stock F2 | 10,000 | $0.00 | $0.00 |
Holdings After Transaction:
Class A Common Stock — 200,252 shares (Direct)
Footnotes (2)
- F1. The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.26 to $17.88 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
- F2. Represents a charitable donation of common stock to a donor advised fund.
Key Figures
Shares sold: 50,000 shares
Weighted average sale price: $17.64 per share
Sale price range: $17.26–$17.88 per share
+1 more
4 metrics
Shares sold
50,000 shares
Class A Common Stock sale on 2026-08-13
Weighted average sale price
$17.64 per share
Open-market sale of 50,000 shares
Sale price range
$17.26–$17.88 per share
Prices for multiple sale transactions on 2026-08-13
Charitable gift shares
10,000 shares
Bona fide gift of Class A Common Stock on 2026-08-13
Key Terms
weighted average price, bona fide gift, donor advised fund
3 terms
weighted average price financial
"The price included is a weighted average price for multiple transactions."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
bona fide gift financial
"Transaction code G is described as a bona fide gift."
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
donor advised fund financial
"Represents a charitable donation of common stock to a donor advised fund."
A donor advised fund is a charitable savings account you fund with cash or assets (including stocks) that lets you take an immediate tax benefit while recommending when and which charities receive grants over time. Think of it like a dedicated piggy bank for giving: you get tax relief when you put money in, can avoid selling appreciated securities and triggering capital gains, and still control the timing and recipients of donations, which affects tax planning, portfolio decisions, and public giving signals.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did AMRX director John Kiely report on this Form 4?
John Kiely reported two transactions in Amneal Pharmaceuticals (AMRX) Class A stock on 2026-08-13: an open-market sale of 50,000 shares and a separate charitable gift of 10,000 shares to a donor advised fund.
Did John Kiely make any charitable donations of AMRX stock in this filing?
Yes. The Form 4 reports that John Kiely made a charitable donation of 10,000 shares of Amneal Pharmaceuticals Class A Common Stock. The gift is described as a contribution to a donor advised fund with no per-share price reported.
Were the AMRX stock sales by John Kiely under a Rule 10b5-1 trading plan?
The Form 4 does not state that these trades were made under a Rule 10b5-1 trading plan. The document-level 10b5-1 checkbox is not marked as affirming plan use, and the bound footnotes do not reference any trading plan.
What does the weighted average sale price mean in John Kiely’s AMRX Form 4?
The Form 4 explains that $17.64 is a weighted average price for multiple trades. It notes that individual sale prices for the 50,000 shares ranged between $17.26 and $17.88, and that detailed trade-level pricing information is available upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.
